1. nevadawriter
2. msrobins66
3. 49363
1.nevadawriter 02/08/2018
Cantor Fitzgerald initiates coverage with Overweight rating, $27 PT
2.msrobins66 04/16/2018
Spero Therapeutics Highlights SPR741 Phase 1 and Preclinical Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW